Alzheimer's disease drug development pipeline: 2021
Alzheimer's & Dementia: Translational Research & Clinical Interventions
First page number:
Last page number:
The number of individuals worldwide with Alzheimer's disease (AD) is growing at a rapid rate. New treatments are urgently needed. We review the current pipeline of drugs in clinical trials for the treatment of AD.
Alzheimer’s disease, amyloid, biomarkers, clinicaltrials, Common Alzheimer’s Disease Research Ontology (CADRO), drug development, inflammation, National Institutes of Health, pharmaceutical companies, repurposed drugs, tau
Alzheimer's disease drug development pipeline: 2021.
Alzheimer's & Dementia: Translational Research & Clinical Interventions, 7(1),
Available at: http://dx.doi.org/10.1002/trc2.12179